Premier/Mallinckrodt expand imaging agent supply agreement; J&J/Premier sign supplier deal.
MALLINCKRODT/PREMIER SUPPLY LINK ADDS NUCLEAR IMAGING AGENTS to the list of Mallinckrodt imaging agents covered by sole-source contracts with Premier. The firms announced a new five-year agreement on Feb. 12 under which Mallinckrodt will supply radiopharmaceuticals and related accessories to the Premier health care alliance. The deal is expected to increase Mallinckrodt's annual business with Premier members by up to $100 mil. -- several times the current level, Mallinckrodt says. An April 1996 agreement already covers the supply of contrast media used with x-ray and other imaging modalities.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth